Tubeimoside III
CAS No. 115810-13-4
Tubeimoside III( —— )
Catalog No. M19953 CAS No. 115810-13-4
Tubeimoside III has anti-inflammatory anti-tumor and anti-tumorigenic activities stronger than those of tubeimoside II.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 90 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTubeimoside III
-
NoteResearch use only, not for human use.
-
Brief DescriptionTubeimoside III has anti-inflammatory anti-tumor and anti-tumorigenic activities stronger than those of tubeimoside II.
-
DescriptionTubeimoside III has anti-inflammatory anti-tumor and anti-tumorigenic activities stronger than those of tubeimoside II.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number115810-13-4
-
Formula Weight1365.47
-
Molecular FormulaC64H100O31
-
Purity>98% (HPLC)
-
SolubilityDMSO: Soluble
-
SMILESC[C@@H]1O[C@H]2O[C@@H]3[C@@H](O)[C@@H](O)CO[C@H]3OC(=O)[C@]34CCC(C)(C)C[C@H]3C3=CC[C@@H]5[C@@]6(C)C[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O[C@@H]7O[C@@H](COC(=O)C[C@](C)(O)CC(=O)O[C@@H]1[C@@H](O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]7O)[C@@](C)(CO)[C@@H]6CC[C@@]5(C)[C@]3(C)C[C@H]4O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yu TX et al. Structure-activity relationship of tubeimosides in anti-inflammatory antitumor and antitumor-promoting effects. Acta Pharmacol Sin. 2001 May;22(5):463-8.
molnova catalog
related products
-
Stearyl methacrylate
Stearyl methacrylate (Octadecyl 2-methylprop-2-enoate) is involved in the synthesis of hydrogels and oil-absorbing resins.
-
Antagonist G
Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy.
-
Loureirin C
Loureirin C can inhibit the activities of thrombin in vitro effectively.
Cart
sales@molnova.com